1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25 | On 12/16//2021, Licensing Program Analyst (LPA) Misty Valencia conducted an announced case management investigation visit regarding medication errors. LPA met with Maria Teibel, Direct Care Staff and explained the reason for the visit. Prior to initiating the visit, LPA completed required COVID-19 testing protocols, and a daily self-screening questionnaire for symptoms of COVID-19 infection to affirm no COVID-19 related symptoms; contacted Administrator and completed a facility risk assessment. LPA ensured they applied hand sanitizer before entering the facility and the following Personal Protective Equipment (PPE) was worn: Surgical masks. Additionally, LPA was screened by staff at the front door.
LPA explained to Ms. Teibel that while LPA was investigating complaint #25-AS-20211008112012 and reviewing records, LPA observed that R1 had a missed medication error on R1's Medication Administration Record (MARS).
The following deficiencies were observed at today’s visit (see LIC 809D ) and cited from the California Code of Regulations, Title 22, and California Health and Safety Code. Failure to correct the deficiencies may result in civil penalties.
Exit interview conducted, report copy was emailed to Licensee, and appeal rights provided.
|